This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FluINsure

GlaxoSmithKline plc

Drug Names(s): FluINsure

Description: FluINsure is an intranasal, non-living, sub-unit vaccine consisting of Proteosomes formulated with influenza antigen preparations in a manner that facilitates intimate association between the Proteosomes and the flu antigens.

Deal Structure: GlaxoSmithKline acquired FluINsure through its acquisition of ID Biomedical. In September 2005, GlaxoSmithKline and ID Biomedical Corporation announced a definitive agreement for GSK to acquire ID Biomedical. In December 2005, ID Biomedical announced that the acquisition by GlaxoSmithKline closed and ID Biomedical is now a wholly-owned subsidiary of GSK.


FluINsure News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug